CNE000000Y37
CNE000000Y37
JINYU BIO-TECHNOLOGY CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 13.02B EUR | 12.95B EUR | 16.01B EUR | 16.75B EUR |
Enterprise Value | 11.45B EUR | 11.44B EUR | 14.77B EUR | 15.49B EUR |
Valuation Multiples | ||||
Trailing P/E | 91.08x | 301.91x | 4,729.75x | -- |
Forward P/E | 49.33x | -- | -- | -- |
Price to Sales | 8.49x | 11.66x | 16.53x | 17.21x |
Price to Book | 2.38x | 2.39x | 2.93x | 3.12x |
EV/Revenue | 7.47x | 10.31x | 15.25x | 15.91x |
EV/EBITDA | 37.34x | 77.05x | 219.43x | 247.68x |
Price to FCF (P/FCF) | -- | 192.12x | 201.22x | 140.99x |
EV/FCF | -- | 169.76x | 185.63x | 130.36x |
FCF Yield | -0.41% | 0.52% | 0.5% | 0.71% |